Gefitinib vs Upadacitinib

Gefitinib vs Upadacitinib: Overview

This comparison examines the pharmacological differences between Gefitinib and Upadacitinib.

Mechanism of Action

Gefitinib: Selective reversible inhibitor of EGFR tyrosine kinase.

Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.

Pharmacokinetics

Half-life: Gefitinib — 48 hours; Upadacitinib — 9-14 hours.

Chemical Properties

Molecular Formula: Gefitinib — C22H24ClFN4O3; Upadacitinib — C17H19F3N6O.

Molecular Weight: Gefitinib — 446.9000 g/mol; Upadacitinib — 380.3700 g/mol.

Type: Gefitinib — Small molecule; Upadacitinib — Small molecule.